Open-Label Surufatinib in European Patients With NET

Haukeland University Hospital, Bergen

Institut Catala d'Oncologis (ICO) - Hospital Duran i Reynals, Barcelona

Hospital Vall Hebron, Barcelona

Stony Brook Cancer Center, Stony Brook

Charite Universitatsmedizin Berlin, Berlin

Istituto Europeo di Oncologia, Milan

ASST-Spedali Civili di Brescia, Brescia

Hospital Universitario Ramon y Cajal, Madrid

Hospital Universitario 12 de Octubre, Madrid

CHU Bordeaux, Pessac

University of Alabama, Birmingham (UAB), Birmingham

Hospital Universitario Virgen del Rocio, Seville

Universitatsklinikum Essen, Klinik fur Endokrinologie, Essen

Universita degli Studi di Firenze - Azienda Ospedaliero Universitaria Careggi (AOUC), Florence

Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Bari

Houston Methodist, Houston

Universitaetsklinikum Erlangen, Erlangen

University of California Irvine Medical Center UCIMC - H.H. Chao Comprehensive Digestive Disease Center CDDC, Orange

Institut Gustave Roussy, Villejuif

Emory University, Winship Cancer Institute, Atlanta

Oslo University Hospital Rikshospitalet, Oslo

Sarah Cannon Research Institute, London

Christie Hospital, Manchester